Price $1.60 |
Market Cap
25.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.69
|
P/S
24.45
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-5.2K
|
FCF
-2.5
|
|
Op. Margin
-988.50%
|
Net Margin
-980.30%
|
ROE
-174.20%
|
ROI
-67.80%
|
|
ROA
-132.20%
|
EPS Growth
33.10%
|
Current Ratio
9.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Champions Oncology Inc (CSBR) | $9.44 | - | - | 116.2M | Strong Buy |
| Endo International PLC (ENDP) | $3.12 | - | - | 785.6M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $11.57 | - | - | 12.39B | Strong Buy |
| Allied Healthcare Products Inc (AHPI) | $8.35 | - | - | 43.3M | Strong Buy |
| Bausch Health Companies Inc (BHC) | $17.19 | - | - | 6.75B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
